ClinicalTrials.gg
DrugCombination product

Survodutide clinical trials

Also written BI 456906.

studies test it
36
open now
8
in phase 3
12
first study started
2017

How each study uses survodutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the survodutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Survodutide
25
Survodutide formulation A
3
Survodutide formulation B2
2

Development codes

BI 456906
29

Studies by the year they started

36 studies that test it; most in 2024 (11)

Studies that test survodutide, by start year
YearStudies
20171
20181
20202
20212
20222
20235
202411
20254
20268

By phase

A phase 1/2 study counts in both.

Phase 1
20
Phase 2
4
Phase 3
12

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 35 · Other 1

Boehringer Ingelheim (35) · University Medical Center Groningen (1)

Often tested with

Tested in the same studies.

BI 1820237 (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test survodutide.

Studies

Open first, then newest update. How each study uses survodutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test survodutide →

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call survodutide · ClinicalTrials.gg INT002004

  • MeSH (NLM) C000726451survodutideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2ALA66NS64SURVODUTIDEConfirmed FDA, NLM
  • NCI Thesaurus C199114SurvodutideOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.